Market Overview:
The global tissue engineering market is expected to reach USD XX million by 2030, at a CAGR of XX% during the forecast period 2018-2030. The market growth is attributed to the increasing demand for tissue engineered products for various applications such as neurology, cardiology & vascular, skin & integumentary and others. In addition, the increasing number of research and development activities in this field is also contributing to the growth of this market. However, high cost associated with tissue engineering products may restrain the growth of this market during the forecast period. Based on type, synthetic materials segment accounted for a major share in 2017 and it is projected to maintain its dominance throughout the forecast period. This can be attributed to their properties such as biocompatibility and easy processing which make them suitable for use in various applications. Based on application, neurology segment held a dominant share in 2017 and it is projected to maintain its lead throughout the forecast period owing to rising incidence of neurological disorders across globe.
Product Definition:
Tissue engineering is the process of creating functional tissues in vitro for use in transplantation, drug testing, and other biomedical applications.
Synthetic Materials:
Synthetic materials are man-made and are different from natural products. They have been designed to perform specific functions in the body, which natural products do not fulfill. Some of the common synthetic materials used for tissue engineering include polymers, ceramics, composites & alloys and biopolymers such as proteins & DNA.
Biologically Derived Materials:
Biological materials are being used in the field of tissue engineering for replacement or restoration of body parts. The most commonly used biological material is human cadaveric dermis which is derived from a patient's own body through surgical excision. Other sources include animal tissues, such as porcine and bovine dermis, avian carpometacarpal ligament (ACML), equine tendons, and equine cornea among others.
Application Insights:
The others segment includes oncology, urology, ophthalmology, and thoracic surgery. The application of tissue engineered products in other surgical procedures is yet to be established. However there are several ongoing clinical trials that focus on the use of these products for various diseases such as Parkinson¢â‚¬â„¢s disease and lung cancer. In addition to this numerous research initiatives are being taken by government institutions and private companies with the objective to increase knowledge regarding tissue engineered grafts in other applications including orthopedics and spinal fusion surgeries.
Cardiology & vascular was one of the prominent segments contributing towards revenue generation in 2017 owing to increasing usage of synthetic materials for cardiovascular implants over natural tissues due largely to their high mechanical strength properties which make them ideal for implantable devices such as pacemakers or artificial valves that require minimal movement when compared with living human organs do.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of industry players, increased research activities for development of advanced products, and availability of adequate funding for R&D. The U.S.-based companies are engaged in extensive research on cell-based therapies as well as tissue engineering applications that are expected to propel regional growth over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to increasing healthcare spending by governments and private sectors coupled with rising awareness regarding regenerative medicine in this region which is expected to drive demand from 2018 to 2030 time frame). Moreover, growing medical tourism industry due’s major contribution towards revenue generation will also boost demand further over next eight years (2030).
Growth Factors:
- Increasing demand for tissue engineering products for wound healing and regenerative medicine applications
- Rising prevalence of chronic diseases that require tissue engineering therapies
- Growing number of research and development activities in the field of tissue engineering
- Technological advancements in the field of tissue engineering
- increasing investments by private and public organizations for research and development in the field
Scope Of The Report
Report Attributes
Report Details
Report Title
Tissue Engineering Market Research Report
By Type
Synthetic Materials, Biologically Derived Materials
By Application
Neurology, Cardiology & Vascular, Skin & Integumentary, Others
By Companies
Allergan, Integra Lifesciences, C. R. Bard, Zimmer Biomet, Organogenesis, Osiris Therapeutics, Cryolife, ACell, Biocomposites, DSM, Episkin, J-TEC, Athersys, Biotime, B. Braun, International Stem Cell, Bio Tissue Technologies
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
242
Number of Tables & Figures
170
Customization Available
Yes, the report can be customized as per your need.
Global Tissue Engineering Market Report Segments:
The global Tissue Engineering market is segmented on the basis of:
Types
Synthetic Materials, Biologically Derived Materials
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Neurology, Cardiology & Vascular, Skin & Integumentary, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Allergan
- Integra Lifesciences
- C. R. Bard
- Zimmer Biomet
- Organogenesis
- Osiris Therapeutics
- Cryolife
- ACell
- Biocomposites
- DSM
- Episkin
- J-TEC
- Athersys
- Biotime
- B. Braun
- International Stem Cell
- Bio Tissue Technologies
Highlights of The Tissue Engineering Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Synthetic Materials
- Biologically Derived Materials
- By Application:
- Neurology
- Cardiology & Vascular
- Skin & Integumentary
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Tissue Engineering Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Tissue engineering is the process of creating replacement tissues and organs from scratch using biotechnology.
Some of the major players in the tissue engineering market are Allergan, Integra Lifesciences, C. R. Bard, Zimmer Biomet, Organogenesis, Osiris Therapeutics, Cryolife, ACell, Biocomposites, DSM, Episkin, J-TEC, Athersys, Biotime, B. Braun, International Stem Cell, Bio Tissue Technologies.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Tissue Engineering Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Tissue Engineering Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Tissue Engineering Market - Supply Chain
4.5. Global Tissue Engineering Market Forecast
4.5.1. Tissue Engineering Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Tissue Engineering Market Size (000 Units) and Y-o-Y Growth
4.5.3. Tissue Engineering Market Absolute $ Opportunity
5. Global Tissue Engineering Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Tissue Engineering Market Size and Volume Forecast by Type
5.3.1. Synthetic Materials
5.3.2. Biologically Derived Materials
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Tissue Engineering Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Tissue Engineering Market Size and Volume Forecast by Application
6.3.1. Neurology
6.3.2. Cardiology & Vascular
6.3.3. Skin & Integumentary
6.3.4. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Tissue Engineering Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Tissue Engineering Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Tissue Engineering Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Tissue Engineering Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Tissue Engineering Demand Share Forecast, 2019-2026
9. North America Tissue Engineering Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Tissue Engineering Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Tissue Engineering Market Size and Volume Forecast by Application
9.4.1. Neurology
9.4.2. Cardiology & Vascular
9.4.3. Skin & Integumentary
9.4.4. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Tissue Engineering Market Size and Volume Forecast by Type
9.7.1. Synthetic Materials
9.7.2. Biologically Derived Materials
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Tissue Engineering Demand Share Forecast, 2019-2026
10. Latin America Tissue Engineering Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Tissue Engineering Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Tissue Engineering Market Size and Volume Forecast by Application
10.4.1. Neurology
10.4.2. Cardiology & Vascular
10.4.3. Skin & Integumentary
10.4.4. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Tissue Engineering Market Size and Volume Forecast by Type
10.7.1. Synthetic Materials
10.7.2. Biologically Derived Materials
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Tissue Engineering Demand Share Forecast, 2019-2026
11. Europe Tissue Engineering Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Tissue Engineering Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Tissue Engineering Market Size and Volume Forecast by Application
11.4.1. Neurology
11.4.2. Cardiology & Vascular
11.4.3. Skin & Integumentary
11.4.4. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Tissue Engineering Market Size and Volume Forecast by Type
11.7.1. Synthetic Materials
11.7.2. Biologically Derived Materials
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-YGrowth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Tissue Engineering Demand Share, 2019-2026
12. Asia Pacific Tissue Engineering Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Tissue Engineering Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Tissue Engineering Market Size and Volume Forecast by Application
12.4.1. Neurology
12.4.2. Cardiology & Vascular
12.4.3. Skin & Integumentary
12.4.4. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Tissue Engineering Market Size and Volume Forecast by Type
12.7.1. Synthetic Materials
12.7.2. Biologically Derived Materials
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Tissue Engineering Demand Share, 2019-2026
13. Middle East & Africa Tissue Engineering Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Tissue Engineering Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Tissue Engineering Market Size and Volume Forecast by Application
13.4.1. Neurology
13.4.2. Cardiology & Vascular
13.4.3. Skin & Integumentary
13.4.4. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Tissue Engineering Market Size and Volume Forecast by Type
13.7.1. Synthetic Materials
13.7.2. Biologically Derived Materials
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Tissue Engineering Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Tissue Engineering Market: Market Share Analysis
14.2. Tissue Engineering Distributors and Customers
14.3. Tissue Engineering Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Allergan
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Integra Lifesciences
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. C. R. Bard
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Zimmer Biomet
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Organogenesis
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Osiris Therapeutics
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Cryolife
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. ACell
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Biocomposites
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. DSM
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Episkin
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. J-TEC
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Athersys
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Biotime
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. B. Braun
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. International Stem Cell
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. Bio Tissue Technologies
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook